Powered By
After fourteen months having been given 4 different chemotherapeutic meds I am still not in complete remission, though I've recently been told I'm in "very good partial remission." I've not only read about Car-T but I had a very close friend who did undergo this procedure. It did extend his life but it also gave him
leukemia as a side effect. I'm aware the potential for short term side effects can be quite harsh and that somewhere between 5-7% of patients may have long term side effects that… read more
Perhaps you are thinking of Abecma, which is the only other car-t for MM and only has a potential remission of a year. Carvykti offers a potential three year remission which would be an advantage for me. At least that is my hope. I am feeling quite well these days so it is difficult to agree to a few months of harsh side effects.
Thanks and much appreciated!David
I recently read that relapse happens on average around 8-12 months later. I’m not sure I would want to go through all that for such a short time. I was looking for the article to share with you, but I think you could find it on Patient Power.
Paula🌹
CAR-T cell therapy is specifically designed for people with myeloma that is refractory (resistant to treatment) or has relapsed, which seems relevant to your situation. The treatment works by modifying your own T cells to better fight cancer cells, and it can be effective when other treatments haven't achieved complete Show Full Answer
Join
Your Privacy Choices
